Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of ...

Boston Scientific Corporation today announced positive 12-month primary endpoint results from the second phase of the ...

With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing ...

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, today announced the initiation of the ...

Boston Scientific (BSX) announced positive 12-month primary endpoint results from the second phase of the ADVANTAGE AF clinical trial ...

Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

A new study published in the Journal of the American College of Cardiology showed that the patients with atrial fibrillation ...

The biomedical market’s latest technology for treating irregular heartbeats has made its way to the Flathead Valley, bringing ...

Field Medical Inc. reaped $40 million in its series A fundraising via $20 million in new capital and conversion of $20 ...

The Vatican announced that Pope Francis died from a stroke that was followed by a coma and irreversible cardiocirculatory ...